Exhibit 23.1

 

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We hereby consent to the use in this Registration Statement on Form F-4 of Maius Pharmaceutical Co., Ltd of our report dated February 28, 2025, relating to the consolidated financial statements of Maius Pharmaceutical Co., Ltd and Subsidiaries as of and for the years ended September 30, 2024 and 2023, which appear in this Registration Statement.

 

We also consent to the reference to us under the heading “Experts” in such Registration Statement.

 

/s/ Wei, Wei & Co., LLP

 

Flushing, New York

June 13, 2025